1,041 material Form 8-K filings that 824 companies we cover made with the SEC in November 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Abercrombie & Fitch reported third-quarter fiscal 2025 results on November 25, 2025, with net sales up 7% to $1.3 billion, while diluted earnings per share fell to $2.36 from $2.50 and operating margin declined to 12.0% from 14.8%. The company narrowed its full-year net income per diluted share outlook to $10.20 to $10.50 from $10.00 to $10.50, raising the low end of the range, and repurchased $100 million of shares in the quarter.
Q3 net sales of $1.3 billion, up 7% from a year earlier; comparable sales rose 3%.
Operating income of $155 million vs. $179 million a year earlier; diluted EPS of $2.36 vs. $2.50.
Full-year fiscal 2025 diluted EPS outlook narrowed to $10.20 to $10.50 from $10.00 to $10.50; Q4 EPS outlook is $3.40 to $3.70.
$100 million of shares repurchased in Q3; $950 million remains on the March 2025 authorization.
HP reported fiscal 2025 results on November 25, 2025, with net revenue of $55.3 billion, up 3.2%, while GAAP diluted EPS fell 5.7% to $2.65 and non-GAAP diluted EPS fell 9.0% to $3.12. The same day, the Board approved an AI-focused plan with approximately $650 million in restructuring and other charges and estimated gross run rate savings of approximately $1 billion by the end of fiscal 2028. The company also raised its quarterly dividend to $0.30 per share, and its fiscal 2026 non-GAAP diluted EPS outlook is $2.90 to $3.20.
FY25 net revenue was $55.3 billion, up 3.2%; GAAP diluted EPS was $2.65, down from $2.81 a year earlier.
The plan includes approximately $650 million in restructuring and other charges, of which approximately $550 million is cash, with approximately $250 million in fiscal 2026.
Workforce reductions of approximately 4,000 to 6,000 employees are expected by the end of fiscal 2028, with about $400 million of the charges in labor costs.
Quarterly dividend increases to $0.30 per share, payable January 2, 2026 to holders of record as of December 11, 2025.
Arrowhead reported fiscal 2025 results for the year ended September 30, 2025, with revenue of $829.4 million, up from $3.6 million a year earlier. The company's net loss attributable to Arrowhead narrowed to $1.6 million, or $0.01 per diluted share, from $599.5 million, or $5.00 per share, in fiscal 2024, driven largely by milestone payments from Sarepta Therapeutics and the Novartis licensing deal.
Revenue was $829.4 million for fiscal 2025 versus $3.6 million for fiscal 2024.
Operating income was $98.3 million versus an operating loss of $601.1 million a year earlier.
Net loss attributable to Arrowhead was $1.6 million, or $0.01 per diluted share, versus $599.5 million, or $5.00 per share.
The FDA approved REDEMPLO (plozasiran) for adults with familial chylomicronemia syndrome, and the company received a $200 million upfront payment from Novartis.
Dell Technologies reported fiscal third-quarter 2026 results for the quarter ended October 31, 2025, with revenue of $27.0 billion, up 11% year over year, and GAAP diluted EPS of $2.28, up 39%. The company raised its AI server shipment guidance to roughly $25 billion and full-year revenue guidance to a midpoint of $111.7 billion, which points to stronger expected results for shareholders.
Third-quarter revenue of $27.0 billion, up 11%; ISG revenue up 24% to $14.1 billion
GAAP diluted EPS of $2.28, up 39%; non-GAAP diluted EPS of $2.59, up 17%
FY26 revenue guidance of $111.2 billion to $112.2 billion; fourth-quarter revenue guidance of $31.0 billion to $32.0 billion
Returned $1.6 billion to shareholders in the quarter; David Kennedy named chief financial officer on a permanent basis
CleanSpark reported fiscal year 2025 results for the year ended September 30, 2025, with revenue of $766.3 million, up 102.2% from $379 million, and net income of $364.5 million, or $1.25 per basic share, compared with a net loss of $145.8 million a year earlier. The filing notes a $425.6 million gain on the fair value of bitcoin within operating results, and the company cites a recently closed $1.15 billion 0% convertible transaction for expansion of its power and land portfolio.
Revenue of $766.3 million, up $387.3 million from the prior year
Net income of $364.5 million ($1.25 basic per share) versus a net loss of $145.8 million ($0.69 per share) in fiscal 2024
Adjusted EBITDA of $823.4 million, up from $245.8 million; the company will no longer exclude bitcoin impairments or realized bitcoin gains from this measure
Long-term debt of $644.6 million and cash of $43.0 million as of September 30, 2025
Autodesk reported fiscal third-quarter 2026 revenue of $1.85 billion, up 18% from a year earlier, with GAAP diluted earnings per share of $1.60 versus $1.27. The company raised its full-year fiscal 2026 guidance, which now includes revenue of $7.150 billion to $7.165 billion and GAAP EPS of $5.16 to $5.33.
Q3 fiscal 2026 revenue was $1,853 million, up 18% as reported and in constant currency; Americas $820 million, EMEA $715 million, APAC $318 million.
GAAP diluted EPS was $1.60 versus $1.27 a year earlier; non-GAAP EPS was $2.67, up $0.50 year over year.
Full-year fiscal 2026 guidance now calls for revenue of $7,150 million to $7,165 million and non-GAAP EPS of $10.18 to $10.25; the prior guidance figures are not in the filing.
J.M. Smucker reported fiscal 2026 second-quarter net sales of $2.3 billion, up 3%, driven by higher net pricing, while adjusted earnings per share fell 24% to $2.10. The company narrowed its full-year adjusted EPS guidance to $8.75 to $9.25 from $8.50 to $9.50, which keeps the midpoint at $9.00 unchanged.
Net sales were $2,330.1 million, up 3% from $2,271.2 million; excluding divestitures and currency, sales rose 5%.
Adjusted EPS was $2.10 versus $2.76 a year earlier; GAAP diluted EPS was $2.26 versus a loss of $0.23.
Fiscal 2026 adjusted EPS guidance is $8.75 to $9.25, down from the prior $8.50 to $9.50 range at the top end and up at the bottom; net sales growth guidance is 3.5% to 4.5%.
Free cash flow was $280.2 million versus $317.2 million a year earlier; full-year free cash flow guidance is unchanged at $975.0 million.
DICK'S Sporting Goods reported third-quarter results that showed higher sales but a sharp drop in GAAP earnings per share, which fell to $0.86 from $2.75 a year earlier, largely reflecting the September 8, 2025 Foot Locker acquisition. The company raised its full-year 2025 comparable sales and EPS outlook for the DICK'S Business, while expecting future pre-tax charges of $500 million to $750 million tied to reviewing unproductive Foot Locker assets and merger costs.
Q3 GAAP EPS was $0.86 versus $2.75 a year earlier; non-GAAP EPS for the DICK'S Business was $2.78 versus $2.75
Full-year 2025 DICK'S Business EPS guidance raised to $14.25 to $14.55 from $13.90 to $14.50; comparable sales guidance raised to 3.5% to 4.0% from 2.0% to 3.5%
Foot Locker acquired September 8, 2025 for $2.5 billion; Q4 Foot Locker gross margin expected to be down 1,000 to 1,500 basis points
Quarterly dividend of $1.2125 per share declared, payable December 26, 2025 to holders of record on December 12, 2025
Best Buy reported third-quarter fiscal 2026 results with enterprise revenue of $9.67 billion and comparable sales up 2.7%, after a 2.9% decline a year earlier. GAAP diluted EPS fell to $0.66 from $1.26 because of a $171 million goodwill and intangible impairment tied to Best Buy Health, while adjusted diluted EPS rose to $1.40 from $1.26. The company raised its FY26 adjusted diluted EPS guidance to $6.25 to $6.35 from $6.15 to $6.30.
Enterprise revenue of $9,672 million in Q3 FY26 vs. $9,445 million a year earlier; comparable sales up 2.7%
GAAP diluted EPS of $0.66 vs. $1.26 last year, reflecting $192 million of Best Buy Health impairments in the quarter
Adjusted diluted EPS of $1.40 vs. $1.26 last year
FY26 guidance raised: adjusted diluted EPS to $6.25 to $6.35 (from $6.15 to $6.30) and revenue to $41.65 billion to $41.95 billion (from $41.1 billion to $41.9 billion)
Kohl's reported third-quarter fiscal 2025 results, with net sales down 2.8% to $3.4 billion and diluted EPS of $0.07 versus $0.20 a year earlier. The company raised its full-year 2025 outlook, though it still expects net sales to fall 3.5% to 4%, and named Michael Bender permanent CEO. Shareholders face a mixed picture: weaker sales and profit in the quarter alongside a higher full-year outlook.
Q3 net sales fell 2.8% to $3.4 billion; comparable sales fell 1.7%
Q3 diluted EPS was $0.07 versus $0.20 a year earlier; adjusted diluted EPS was $0.10 versus $0.20
Full-year 2025 adjusted diluted EPS guidance is $1.25 to $1.45; net sales guidance is a decrease of 3.5% to 4%
Nine-month net income of $147 million included a $129 million gain on a credit card interchange fee lawsuit settlement
Burlington Stores reported third-quarter 2025 results with total sales up 7% to $2,706 million and net income of $105 million, or $1.63 per share, versus $1.40 a year earlier. The company raised its full-year 2025 adjusted EPS guidance to $9.69 to $9.89, but comparable store sales rose only 1% and merchandise inventories grew 15%.
Third-quarter total sales rose 7% to $2,706 million; comparable store sales rose 1%.
Third-quarter net income was $105 million, or $1.63 per share, versus $91 million, or $1.40 per share, a year earlier.
Full-year 2025 adjusted EPS guidance raised to $9.69 to $9.89, versus $8.35 last year; fourth-quarter comparable store sales guidance kept at 0% to 2%.
Keysight reported fourth-quarter and fiscal 2025 results, with quarterly revenue of $1.42 billion, up from $1.29 billion a year earlier, and GAAP net income of $229 million, or $1.33 per diluted share, compared with a GAAP net loss of $73 million a year earlier. The board also authorized a new share repurchase program of up to $1.5 billion, and the company guided first-quarter fiscal 2026 revenue to $1.53 billion to $1.55 billion.
Q4 non-GAAP EPS was $1.91, versus $1.65 a year earlier; GAAP diluted EPS was $1.33, versus a loss of $0.42.
Fiscal 2025 revenue was $5.37 billion, up from $4.98 billion, and GAAP net income was $846 million, or $4.89 per diluted share.
Q4 free cash flow fell to $188 million from $328 million a year earlier, and the new $1.5 billion buyback replaces the previous program.
Woodward reported fiscal 2025 net sales of $3.6 billion, up 7%, and diluted earnings per share of $7.19, up 20%, for the year ended September 30, 2025. The company also guided fiscal 2026 EPS to $7.50 to $8.00 and the board authorized a new three-year $1.8 billion share repurchase program.
Fiscal 2025 net sales were $3.6 billion, up 7%, and net earnings were $442 million, up 19%.
Fourth quarter 2025 net sales were $995 million, up 16%, and diluted EPS was $2.23, up 64%.
Fiscal 2026 guidance calls for EPS of $7.50 to $8.00 and total sales growth of 7% to 12%.
The board authorized a new three-year $1.8 billion share repurchase program.
Matthews International reported fourth-quarter fiscal 2025 sales of $318.8 million, down 28.6% from a year earlier, and a GAAP net loss of $27.5 million, or $0.88 per diluted share, compared with a loss of $68.2 million a year earlier. The company said the SGK divestiture was a significant factor in the year-over-year comparison. It also targets fiscal 2026 adjusted EBITDA of at least $180 million, below the $187.5 million reported for fiscal 2025.
Q4 sales of $318.8 million vs. $446.7 million a year earlier; fiscal 2025 sales of $1.50 billion vs. $1.80 billion
Q4 non-GAAP EPS of $0.50 vs. $0.55 a year earlier; fiscal 2025 non-GAAP EPS of $1.26 vs. $2.17
Fiscal 2026 adjusted EBITDA target of at least $180 million, including the 40% share of Propelis, vs. $187.5 million in fiscal 2025
Pending warehouse automation sale is expected to reduce the net leverage ratio below 3.0x, with proceeds mainly for debt reduction
UGI reported fiscal 2025 results for the year ended September 30, 2025, with GAAP net income of $678 million, up from $269 million, and full-year revenues of $7,287 million, up from $7,210 million. The company also issued fiscal 2026 adjusted diluted EPS guidance of $2.90 to $3.15, which assumes normal weather and the current tax regime, compared with fiscal 2025 adjusted diluted EPS of $3.32.
GAAP diluted EPS was $3.09 for fiscal 2025, versus $1.25 in fiscal 2024; adjusted diluted EPS was $3.32, versus $3.06.
Fourth-quarter GAAP net loss attributable to UGI narrowed to $13 million from $273 million a year earlier.
Fiscal 2026 adjusted diluted EPS guidance range is $2.90 to $3.15, and the company raised its expected EPS compound annual growth rate to 5% to 7% between FY24 and FY29.
Available liquidity was approximately $1.6 billion, with leverage of 3.9x at UGI Corporation and 4.9x at AmeriGas Propane.
BJ's Wholesale Club Holdings reported third-quarter fiscal 2025 results for the thirteen weeks ended November 1, 2025. Total revenues rose 4.9% to $5.35 billion, but net income fell 2.4% to $152.1 million and diluted EPS slipped to $1.15 from $1.17. The company raised its adjusted EPS outlook for fiscal 2025 to $4.30 to $4.40.
Total revenues rose 4.9% to $5.35 billion; net sales rose 4.8% to $5.22 billion
Net income fell 2.4% to $152.1 million; diluted EPS was $1.15 versus $1.17; adjusted EPS was $1.16 versus $1.18
Fiscal 2025 adjusted EPS outlook raised to $4.30 to $4.40; comparable club sales excluding gasoline guided to rise 2.0% to 3.0%
Membership fee income rose 9.8% to $126.3 million; the company repurchased $87.3 million of stock in the quarter
Gap Inc. reported third quarter fiscal 2025 net sales of $3.9 billion, up 3% from a year earlier, with comparable sales up 5%. Diluted earnings per share fell to $0.62 from $0.72, and the company raised its full-year operating margin outlook and its net sales growth outlook, which shareholders should weigh against the lower quarterly profit.
Q3 net sales $3.9 billion, up 3%; comparable sales up 5%, the seventh straight quarter of positive comparable sales
Q3 net income $236 million vs. $274 million a year earlier; diluted EPS $0.62 vs. $0.72
Fiscal 2025 operating margin outlook raised to approximately 7.2% from 6.7% to 7.0%; net sales growth outlook raised to 1.7% to 2.0%
Board approved a fourth quarter fiscal 2025 dividend of $0.165 per share
Ross Stores reported third-quarter fiscal 2025 results for the 13 weeks ended November 1, 2025, with diluted earnings per share of $1.58 versus $1.48 a year earlier and net income of $512 million versus $489 million. Sales rose 10% to $5.6 billion and comparable store sales increased 7%. The company raised its fiscal 2025 EPS guidance to $6.38 to $6.46, which benefits shareholders by signaling higher expected full-year profit.
Q3 diluted EPS was $1.58 versus $1.48; net income was $512 million versus $489 million
Q3 sales grew 10% to $5.6 billion; comparable store sales rose 7%
Fiscal 2025 EPS guidance raised to $6.38 to $6.46; Q4 EPS guidance set at $1.77 to $1.85
Repurchased $262 million of stock in Q3 and remains on track to buy back $1.05 billion in fiscal 2025
Walmart reported third-quarter results for the period ended October 31, 2025, with revenue up 5.8% to $179.5 billion and GAAP EPS of $0.77, up from $0.57. The company raised its fiscal 2026 adjusted EPS outlook to $2.58 to $2.63, and it also said it will move its common stock and notes from the NYSE to Nasdaq, with trading on Nasdaq starting December 9, 2025.
Revenue of $179.5 billion, up 5.8%; operating income fell 0.2% to $6.7 billion, mainly due to a non-cash share-based compensation charge at PhonePe
GAAP EPS of $0.77 versus $0.57 a year earlier; adjusted EPS of $0.62
Fiscal 2026 adjusted EPS outlook raised to $2.58 to $2.63, from $2.52 to $2.62 in the August 21, 2025 update
NYSE trading ends at market close December 8, 2025; Nasdaq trading begins at market open December 9, 2025, under the same symbols
Universal Technical Institute reported fiscal 2025 revenue of $835.6 million, up 14.0%, and net income of $63.0 million, up 50.0%, with diluted EPS of $1.13 versus $0.75. For fiscal 2026 it guided to net income of $40 million to $45 million and diluted EPS of $0.71 to $0.80, both down 33% at the midpoint, and it said planned growth investments will temporarily moderate margins.
FY2025 revenue $835.6 million, up 14.0%; net income $63.0 million, up 50.0%; diluted EPS $1.13 versus $0.75
Q4 FY2025 revenue $222.4 million, up 13.3%; Q4 net income $18.8 million, flat versus $18.8 million; Q4 adjusted EBITDA $36.8 million, down 1.4%
FY2026 guidance: revenue $905 million to $915 million; net income $40 million to $45 million; adjusted EBITDA $114 million to $119 million versus $126.5 million in FY2025
Company expects to open at least two and up to five campuses and launch about 20 new programs annually, pending regulatory approval
TJX reported third-quarter fiscal 2026 net sales of $15.1 billion, up 7%, and diluted earnings per share of $1.28, up 12% from $1.14 a year earlier. The company raised its full-year fiscal 2026 guidance for comparable sales, pretax profit margin and diluted EPS, and expects to repurchase about $2.5 billion of stock in the fiscal year.
Q3 consolidated comparable sales rose 5%, and pretax profit margin was 12.7%, up from 12.3% a year earlier.
Full-year fiscal 2026 diluted EPS outlook raised to $4.63 to $4.66, a 9% increase over the prior year's $4.26.
Returned $1.1 billion to shareholders in Q3 through $594 million of buybacks and $472 million of dividends.
Q4 fiscal 2026 guidance unchanged: comparable sales up 2% to 3% and diluted EPS of $1.33 to $1.36.
Williams-Sonoma reported third-quarter 2025 results with net revenues of $1.88 billion, comparable brand revenue up 4.0%, and diluted EPS of $1.96, up from $1.87 a year earlier. The company raised its fiscal 2025 operating margin guidance to 17.8% to 18.1% and approved a new $1 billion stock repurchase authorization, which takes effect once the current program is used up.
Q3 net revenues of $1.88 billion; comparable brand revenue up 4.0%, versus a decline of 2.9% in the prior-year quarter
Q3 operating margin of 17.0% and diluted EPS of $1.96, compared with $1.87 a year earlier
Fiscal 2025 operating margin outlook raised to 17.8% to 18.1%; comparable brand revenue growth of 2% to 5% reiterated
As of November 2, 2025, $637 million remained under the September 2024 buyback; a new $1 billion authorization was approved in November 2025
Lowe's reported third-quarter 2025 sales of $20.8 billion, up from $20.2 billion a year earlier, but diluted EPS fell to $2.88 from $2.99. Adjusted diluted EPS rose 5.9% to $3.06 after excluding $129 million in acquisition-related expenses. The company raised its full-year sales outlook to $86.0 billion but lowered its comparable sales and adjusted operating margin outlook, so the update is mixed for shareholders.
Net earnings were $1.6 billion ($1,616 million) versus $1.7 billion ($1,695 million) in the prior-year quarter.
Comparable sales rose 0.4%, with online sales up 11.4%.
Full-year comparable sales are now expected to be flat, previously flat to up 1%; adjusted operating margin is now 12.1%, previously 12.2% to 12.3%.
Full-year adjusted diluted EPS is now approximately $12.25, previously $12.20 to $12.45.
Griffon reported fiscal 2025 revenue of $2.5 billion, down 4% from the prior year, and net income of $51.1 million ($1.09 per share), down from $209.9 million ($4.23 per share). Results included a $217.2 million net-of-tax charge for third-quarter goodwill and intangible asset impairments in the Consumer and Professional Products segment, while adjusted net income rose to $263.6 million ($5.65 per share). The company also announced a 22% increase in its regular quarterly dividend to $0.22 per share.
Fiscal 2025 revenue was $2.5 billion, down 4% from $2.6 billion; fourth-quarter revenue was $662.2 million, up from $659.7 million.
Fourth-quarter net income was $43.6 million ($0.95 per share), down from $62.5 million ($1.29 per share); adjusted net income was $70.9 million ($1.54 per share) versus $70.9 million ($1.47 per share).
Free cash flow was $323.0 million in fiscal 2025, and leverage fell to 2.4x from 2.6x; the company repurchased 1.9 million shares for $134.7 million.
For fiscal 2026, Griffon expects revenue of $2.5 billion and adjusted EBITDA of $580 million to $600 million.
Valvoline reported fourth-quarter and fiscal 2025 results, with Q4 net revenues up 4% to $453.8 million but reported diluted EPS down 71% to $0.20. The company said it expects to close the $593 million Breeze Autocare acquisition on December 1, 2025, funded by a new $740 million Term Loan B, and gave fiscal 2026 adjusted EPS guidance of $1.60 to $1.70.
Q4 net revenues $453.8 million, up 4%; system-wide same-store sales up 6.0%
Q4 income from continuing operations $25.6 million, down 71%; adjusted EPS $0.45, down 2%
Fiscal 2026 outlook includes Breeze: net revenues $2.0 to $2.1 billion, adjusted EBITDA $525 to $550 million, adjusted EPS $1.60 to $1.70
Breeze deal: $593 million net purchase price, closing planned December 1, 2025; Investor Update scheduled December 11, 2025
Dycom Industries reported fiscal 2026 third-quarter results for the quarter ended October 25, 2025, with contract revenues up 14.1% to $1.452 billion and GAAP net income up to $106.4 million, or $3.63 per diluted share, from $69.8 million, or $2.37, a year earlier. The company raised the midpoint of its fiscal 2026 revenue outlook to a range of $5.350 billion to $5.425 billion and gave fourth-quarter guidance for contract revenues of $1.26 billion to $1.34 billion and diluted EPS of $1.30 to $1.65.
Q3 contract revenues were $1.452 billion, up 14.1%; organic revenue growth was 7.2%
GAAP diluted EPS was $3.63 versus $2.37 a year earlier; net income was $106.4 million versus $69.8 million
Fiscal 2026 contract revenue outlook is $5.350 billion to $5.425 billion, with the midpoint raised
Fourth-quarter fiscal 2026 guidance (quarter ending January 31, 2026): diluted EPS of $1.30 to $1.65
La-Z-Boy reported fiscal second-quarter sales of $522 million, up slightly from a year earlier, while GAAP operating income fell 7% and GAAP diluted EPS was $0.70 versus $0.71. The company also completed a 15-store acquisition, plans to exit non-core businesses, proposed closing its U.K. manufacturing facility, and guided third-quarter sales of $525-545 million.
Sales of $522 million for the quarter ended October 25, 2025, up 0.3%; GAAP operating income of $36.2 million, down 7%.
GAAP diluted EPS of $0.70 versus $0.71 a year earlier; adjusted diluted EPS flat at $0.71.
Third-quarter outlook: sales of $525-545 million and adjusted operating margin of 5.0-6.5%.
Quarterly dividend raised 10% to $0.242 per share, payable December 15, 2025, to holders of record on December 4, 2025.
AECOM reported fiscal fourth-quarter 2025 results with revenue up 2% to $4.2 billion, but GAAP net income fell 22% to $132 million and diluted EPS fell 21% to $0.99. For the full year, net income rose 26% to $638 million and diluted EPS rose 29% to $4.79, and the company initiated fiscal 2026 adjusted EPS guidance of $5.65 to $5.85 along with a review of strategic alternatives for its Construction Management business, including a possible sale. The Board also raised the quarterly dividend 19% to $0.31 per share.
Fiscal Q4 2025: revenue $4.2 billion (up 2%), operating income $237 million (flat), net income $132 million (down 22%), diluted EPS $0.99 (down 21%).
Full year fiscal 2025: revenue $16.1 billion (flat), operating income $1.0 billion (up 24%), net income $638 million (up 26%), diluted EPS $4.79 (up 29%).
Fiscal 2026 adjusted EPS guidance of $5.65 to $5.85 for the enterprise-wide business, or $5.15 to $5.35 excluding Construction Management.
Quarterly dividend raised to $0.31 per share from $0.26, payable January 23, 2026 to holders of record as of January 7, 2026.
Medtronic reported second quarter fiscal 2026 results for the period ended October 24, 2025, with revenue of $8.961 billion and GAAP diluted EPS of $1.07, both up year over year. The company also raised its fiscal 2026 organic revenue growth and adjusted EPS guidance, which matters to shareholders because it signals higher expected earnings for the full year.
Revenue of $8.961 billion rose 6.6% as reported and 5.5% organic; Cardiac Ablation Solutions revenue increased 71%.
GAAP diluted EPS was $1.07, up 8%; non-GAAP diluted EPS was $1.36, also up 8%.
FY26 organic revenue growth guidance raised to approximately 5.5% from approximately 5.0%.
FY26 diluted non-GAAP EPS guidance set at $5.62 to $5.66, versus the prior $5.60 to $5.66, including a potential tariff impact of approximately $185 million.
Home Depot reported third-quarter fiscal 2025 sales of $41.4 billion, up 2.8%, including about $900 million from the GMS acquisition, but diluted earnings per share fell 1.4% to $3.62 and adjusted EPS fell to $3.74 from $3.78. The company said results missed its expectations, citing few storms and weak housing and consumer demand, and it updated its fiscal 2025 guidance to project diluted EPS down about 6.0% from $14.91, which lowers the earnings outlook for shareholders.
Q3 fiscal 2025 net sales $41.4 billion, up $1.1 billion or 2.8%; comparable sales up 0.2%
Q3 diluted EPS $3.62 vs. $3.67 a year earlier; adjusted diluted EPS $3.74 vs. $3.78
Fiscal 2025 guidance: total sales growth about 3.0%, diluted EPS to decline about 6.0% from $14.91, adjusted diluted EPS to decline about 5.0% from $15.24
J&J Snack Foods reported fiscal fourth-quarter net sales of $410.2 million, down 3.9% from the prior year, and diluted EPS of $0.58 versus $1.52, with results hit by $24.1 million of plant closure charges. Full-year net sales rose 1% to $1.58 billion, but full-year diluted EPS fell to $3.36 from $4.45. The company said it has begun a business transformation program it expects to generate at least $20 million of annualized operating income.
Q4 net sales were $410.2 million, down 3.9%; Frozen Beverage segment sales fell 8.3% to $99.6 million.
Q4 operating income was $11.5 million versus $39.8 million a year earlier, including $24.1 million of plant closure charges.
Q4 adjusted EPS was $1.58 versus $1.60; full-year adjusted EPS was $4.27 versus $4.93.
As of September 27, 2025, the company reported $105.9 million in cash and no long-term debt.
Brady Corporation reported fiscal 2026 first-quarter results for the period ended October 31, 2025. Sales rose 7.5% to $405.3 million, and GAAP diluted EPS rose 16.5% to $1.13, while adjusted diluted EPS rose 8.0% to $1.21. The company also raised the low end of its full-year adjusted diluted EPS guidance, which matters to shareholders because it signals a higher expected earnings floor for fiscal 2026.
Q1 net sales were $405.3 million, up 7.5% from $377.1 million, including 2.8% organic growth
Diluted EPS was $1.13 versus $0.97 a year earlier; adjusted diluted EPS was $1.21 versus $1.12
Full-year fiscal 2026 adjusted diluted EPS guidance is now $4.90 to $5.15, up from $4.85 to $5.15 at the low end
GAAP diluted EPS guidance is $4.57 to $4.82, compared with $4.55 to $4.85 previously
Spire reported fiscal 2025 net income of $271.7 million ($4.37 per diluted share), up from $250.9 million a year earlier, and adjusted EPS of $4.44, up 7.5% from $4.13. Operating revenues fell to $2.48 billion from $2.59 billion, and the company issued adjusted EPS guidance of $5.25 to $5.45 for fiscal 2026 and $5.65 to $5.85 for fiscal 2027. The board also raised the quarterly common dividend 5.1% to $0.825 per share.
Fiscal 2025 adjusted earnings were $275.5 million ($4.44 per share) versus $247.4 million ($4.13 per share) in fiscal 2024
Operating revenues were $2,476.4 million versus $2,593.0 million; fourth-quarter net loss was $39.8 million ($0.74 per share) versus $25.9 million ($0.51 per share)
Fiscal 2026 adjusted EPS guidance of $5.25 to $5.45 excludes the pending Piedmont Natural Gas Tennessee acquisition; fiscal 2027 guidance of $5.65 to $5.85 includes it
Quarterly common dividend raised to $0.825 per share, payable January 5, 2026, to holders of record December 11, 2025
MarineMax reported fiscal 2025 fourth-quarter revenue of $552.2 million, down from $563.1 million a year earlier, and a net loss of $0.9 million, or $0.04 per share, compared with net income of $4.0 million a year earlier. For the full year, the company reported a net loss of $31.6 million after a $69.1 million non-cash goodwill impairment, and it issued fiscal 2026 guidance of $110 million to $125 million in adjusted EBITDA and $0.40 to $0.95 per diluted share in adjusted net income.
Q4 fiscal 2025 adjusted EBITDA was $17.3 million, versus $33.5 million in the prior-year quarter.
Q4 gross margin rose to 34.7% from 34.3%, while SG&A expenses rose to $177.6 million from $166.4 million.
Full-year fiscal 2025 reported loss per share was $1.43; adjusted earnings per share was $0.61 versus $2.13 a year earlier.
Fiscal 2026 guidance: adjusted EBITDA of $110 million to $125 million and adjusted net income of $0.40 to $0.95 per diluted share.
Disney reported fourth-quarter and full-year fiscal 2025 results for the period ended September 27, 2025. Full-year revenue rose 3% to $94.4 billion and full-year adjusted EPS rose 19% to $5.93, while fourth-quarter revenue was flat and fourth-quarter adjusted EPS fell 3% to $1.11. For fiscal 2026, Disney guided to double-digit adjusted EPS growth and said it plans to double share repurchases to $7 billion.
Full-year diluted EPS was $6.85, up from $2.72; fourth-quarter diluted EPS was $0.73, up from $0.25
Fourth-quarter total segment operating income fell 5% to $3.5 billion from $3.7 billion
Fiscal 2026 guidance includes double-digit adjusted EPS growth and a share repurchase target of $7 billion, double the fiscal 2025 level
Board declared a cash dividend of $1.50 per share, payable in two installments of $0.75 on January 15, 2026 and July 22, 2026
Edgewell Personal Care reported fourth-quarter and fiscal 2025 results on November 13, 2025, with a fourth-quarter GAAP net loss of $30.6 million after a $51.1 million goodwill impairment tied to its Feminine Care business. Fiscal 2025 GAAP EPS was $0.53, down from $1.97, and the company gave fiscal 2026 guidance that excludes the planned $340 million sale of Feminine Care to Essity.
Q4 net sales were $537.2 million, up 3.8%, but the company posted a GAAP net loss of $30.6 million, or $0.66 per diluted share, versus net income of $8.8 million a year earlier.
Q4 included a non-cash goodwill impairment charge of $51.1 million for the Feminine Care reporting unit.
Fiscal 2025 net sales were $2,223.5 million, down 1.3%, and GAAP diluted EPS was $0.53 versus $1.97 in fiscal 2024.
Fiscal 2026 adjusted EPS is expected at $2.15 to $2.55, compared with fiscal 2025 adjusted EPS of $2.52; the outlook excludes the $340 million Feminine Care divestiture to Essity.
TransDigm reported fourth-quarter fiscal 2025 results for the period ended September 30, 2025, with net sales up 12% to $2,437 million and net income up 30% to $609 million. The company also issued fiscal 2026 guidance calling for net income of $1,906 million to $2,026 million, below fiscal 2025's $2,074 million, which it attributed mainly to added interest expense from fourth-quarter financing.
Q4 net sales $2,437 million, up 12%; net income $609 million, up 30%; EPS $7.75, up 34%
Q4 GAAP EPS reduced by $2.75 from dividend equivalent payments tied to the $90.00 per share special dividend paid September 12, 2025
FY2026 guidance: net sales $9,750 million to $9,950 million; net income $1,906 million to $2,026 million
FY2026 adjusted EPS guidance of $36.49 to $38.53 versus $37.33 in fiscal 2025
Greif reported a two-month fourth quarter ended September 30, 2025, with a net loss from continuing operations of $43.3 million, compared with net income of $34.0 million a year earlier, while Adjusted EBITDA rose 7.4% to $98.9 million. The company also gave low-end fiscal 2026 guidance of $630 million Adjusted EBITDA and $315 million Adjusted free cash flow, raised its cost optimization commitment to $120 million, and plans a share repurchase of about $150 million.
Q4 net loss from continuing operations of $43.3 million, or $(0.73) per diluted Class A share, versus $34.0 million, or $0.58, a year earlier
Adjusted net income fell 98.2% to $0.6 million, or $0.01 per diluted Class A share
Eleven-month fiscal 2025 net income fell 93.2% to $15.1 million, or $0.28 per diluted Class A share; Adjusted EBITDA rose 3.1% to $511.3 million
Containerboard business sold to Packaging Corporation of America for $1.8 billion; timberlands sale for about $462.0 million completed October 1, 2025
StandardAero reported third-quarter 2025 revenue of $1,498.0 million, up 20.4% from a year earlier, and net income of $68.1 million, compared with $16.4 million in the prior-year quarter. The company raised its full-year 2025 guidance for revenue, Adjusted EBITDA and free cash flow, which signals higher expected earnings and cash generation for the year for shareholders. Adjusted EBITDA margin declined to 13.1% from 13.5%.
Q3 2025 revenue was $1,498.0 million, up $253.3 million, or 20.4%, from $1,244.6 million
Q3 2025 net income was $68.1 million, compared with $16.4 million a year earlier
Full-year 2025 revenue guidance raised to $5,970 million to $6,030 million from $5,875 million to $6,025 million
Free cash flow guidance raised to $170 million to $190 million from $155 million to $175 million
Life360 reported unaudited third-quarter 2025 revenue of $124.5 million, up 34% year over year, and net income of $9.8 million, up 27%. It raised full-year 2025 revenue guidance to $474 million to $485 million and Adjusted EBITDA guidance to $84 million to $88 million. It also agreed to acquire Nativo, Inc. in a transaction valued at approximately $120 million in cash and common stock, with completion expected in January 2026.
Q3 2025 Adjusted EBITDA was $24.5 million, up from $9.0 million in Q3 2024.
Q3 2025 net income was $9.8 million, compared with $7.7 million in Q3 2024.
FY2025 revenue guidance raised to $474 million to $485 million from $462 million to $482 million; Adjusted EBITDA guidance raised to $84 million to $88 million from $72 million to $82 million.
Hardware gross profit and margin were affected by tariff-related costs, and Q3 hardware revenue fell 4% year over year to $11.3 million.
Paramount Skydance reported third-quarter 2025 results, with pro forma revenue flat at $6.7 billion versus Q3 2024. The company reported net losses of $244 million before the August 6 deal close and $13 million after it, and issued a 2026 outlook of $30 billion in total revenue and $3.5 billion in adjusted OIBDA. For shareholders, the filing shows flat sales and losses in the reported periods, alongside higher adjusted OIBDA and a raised cost-savings target.
Pro forma Q3 2025 total revenue was $6.7 billion, flat versus $6.7 billion in Q3 2024.
Adjusted OIBDA was $297 million pre-close and $655 million post-close; the company expects Q4 2025 revenue of $8.1 billion to $8.3 billion and 2026 revenue of $30 billion.
Run-rate efficiency target raised to at least $3 billion from $2 billion, and about 1,000 employees were cut at the end of October.
ANI Pharmaceuticals filed an updated investor presentation that restates its third-quarter 2025 results, with total revenue of $228 million, up 54% year over year, and adjusted diluted EPS of $2.04, up 52%. The presentation says the company raised its full-year 2025 guidance for net revenue, adjusted EBITDA and adjusted diluted EPS, with the guidance issued on November 7, 2025. For shareholders, the higher outlook is a positive signal, although ILUVIEN revenue was pressured and the profit figures are non-GAAP measures.
Q3 2025 total revenue was $228 million, up 54% year over year; adjusted non-GAAP EBITDA was $60 million, up 70%; adjusted non-GAAP diluted EPS was $2.04, up 52%.
Full-year 2025 net revenue guidance is $854 million to $873 million, up from a previous $818 million to $843 million.
Full-year 2025 adjusted non-GAAP EBITDA guidance is $221 million to $228 million (previously $213 million to $223 million), and adjusted non-GAAP diluted EPS guidance is $7.37 to $7.64 (previously $6.98 to $7.35).
Q3 2025 ILUVIEN revenue was $17 million, which the company said was pressured by reduced access for Medicare patients and remaining YUTIQ units at physician offices.
RadNet reported third-quarter 2025 revenue of $522.9 million, up 13.4%, and Adjusted EBITDA of $84.9 million, up 15.2%. Net income attributable to RadNet stockholders was $5.4 million, or $0.07 per diluted share, compared with $3.2 million, or $0.04, a year earlier. The company raised its full-year 2025 revenue and Adjusted EBITDA guidance for the Imaging Center segment and its revenue guidance for Digital Health, which is a positive signal for shareholders.
Q3 2025 revenue was $522.9 million, up from $461.1 million; Adjusted EBITDA was $84.9 million, up 15.2%.
Q3 2025 net income attributable to RadNet was $5.4 million, or $0.07 per diluted share, versus $3.2 million, or $0.04, in Q3 2024.
Imaging Center 2025 revenue guidance was raised to $1,900 - $1,930 million and Adjusted EBITDA guidance to $276 - $284 million.
For the first nine months of 2025, the company reported a net loss of $18.1 million, or $(0.24) per share; cash was $804.7 million at September 30, 2025.
Organon reported third-quarter 2025 revenue of $1.602 billion, up 1% as reported and down 1% excluding foreign exchange, while GAAP net income fell to $160 million, or $0.61 per diluted share, from $359 million, or $1.38, a year earlier. The company lowered its full-year 2025 revenue guidance to $6.200 billion to $6.250 billion from $6.275 billion to $6.375 billion, a reduction in its outlook that matters to shareholders. Non-GAAP adjusted diluted EPS rose to $1.01 from $0.87.
Q3 2025 revenue was $1.602 billion, up 1% as reported and down 1% ex-FX; Women's Health fell 3% and Biosimilars rose 19%.
Reported gross margin was 53.5% versus 58.3% a year earlier; one-time manufacturing network optimization costs were the most significant driver.
Full-year 2025 revenue guidance was lowered to $6.200 billion to $6.250 billion; Adjusted EBITDA margin guidance was lowered to about 31.0% from 31.0% to 32.0%.
The board declared a quarterly dividend of $0.02 per share, payable December 11, 2025; Joe Morrissey is interim CEO.
Tyson Foods reported fourth-quarter fiscal 2025 sales of $13,860 million, up 2.2%, and adjusted EPS of $1.15, up 25%, while GAAP EPS fell to $0.13 from $1.00 a year earlier. The company also gave a fiscal 2026 outlook for total adjusted operating income of $2.1 billion to $2.3 billion and raised its quarterly dividend, so shareholders face a mix of higher adjusted results, a sharp GAAP profit decline and a guided adjusted operating income range that sits below fiscal 2025's $2,287 million.
Q4 sales of $13,860 million, up 2.2%; GAAP operating income of $158 million, down 70%
Q4 sales were reduced by $355 million in legal contingency accruals; GAAP EPS of $0.13 versus adjusted EPS of $1.15
Fiscal 2026 outlook: total adjusted operating income of $2.1 billion to $2.3 billion and sales up 2% to 4%, compared with fiscal 2025 adjusted operating income of $2,287 million
Quarterly dividend increased to $0.51 per Class A share, effective November 7, 2025
Maplebear (Instacart) reported third-quarter 2025 revenue of $939 million, up 10% year-over-year, and GAAP net income of $144 million, up 22%. Its board also raised the share repurchase authorization to $2.5 billion from $1 billion, and the company plans a $250 million accelerated share repurchase, which matters to shareholders as a large capital return and a sign of confidence in its cash generation.
Q3 2025 orders of 83.4 million, up 14% year-over-year; GTV of $9,170 million, up 10%
Total revenue $939 million, up 10%; GAAP gross profit $692 million, up 8%, but a lower share of GTV and revenue than in Q3 2024
GAAP net income $144 million, up 22%; adjusted EBITDA $278 million, up 22%
Q4 2025 outlook: GTV of $9,450 million to $9,600 million and adjusted EBITDA of $285 million to $295 million; $250 million accelerated share repurchase with Goldman Sachs expected to begin November 11, 2025
Koppers reported third quarter 2025 net sales of $485.3 million, down 12.4% from $554.3 million a year earlier, and adjusted EBITDA of $70.9 million, down from $77.4 million. GAAP diluted EPS rose to $1.17 from $1.09, but adjusted EPS fell to $1.21 from $1.37. The company cut its 2025 sales forecast to about $1.9 billion from $1.9 billion to $2.0 billion and set adjusted EBITDA guidance of $255 million to $260 million and adjusted EPS of $4.00 to $4.15.
Q3 2025 net sales were $485.3 million vs. $554.3 million, and adjusted EBITDA was $70.9 million vs. $77.4 million.
GAAP diluted EPS was $1.17 vs. $1.09; adjusted EPS was $1.21 vs. $1.37.
2025 sales forecast revised to about $1.9 billion, from $1.9 billion to $2.0 billion previously.
2025 adjusted EBITDA guidance is $255 million to $260 million and adjusted EPS guidance is $4.00 to $4.15; the CEO expects adjusted EPS in the lower half of the previous range.
TDS reported third-quarter 2025 operating revenues from continuing operations of $308.5 million, down from $327.5 million a year earlier, while diluted earnings per share from continuing operations rose to $0.33 from a loss of $0.88. The company also authorized a new $500 million share repurchase program and named Anthony Carlson president and CEO of Array effective November 16, 2025.
Q3 2025 operating revenues from continuing operations: $308.5 million, versus $327.5 million in Q3 2024
Diluted EPS from continuing operations: $0.33, versus $(0.88) a year earlier
Net loss attributable to TDS common shareholders: $(99.1) million for the quarter, per the filing's income statement, including $(139.3) million from discontinued operations
New $500 million share repurchase program, with no expiration; TDS repurchased 1,077,564 shares for $40.7 million in Q3
DoubleVerify reported third-quarter 2025 revenue of $188.6 million, up 11% from a year earlier, with adjusted EBITDA of $65.9 million at a 35% margin. Net income fell to $10.2 million from $18.2 million, and diluted EPS was $0.06 versus $0.10. The company raised its full-year 2025 adjusted EBITDA margin guidance to approximately 33% from 32% and expects full-year revenue growth of approximately 14%.
Q3 2025 revenue of $188.6 million, up 11%; activation revenue $106.7 million, up 10%
Net income of $10.2 million versus $18.2 million in Q3 2024; diluted EPS $0.06 versus $0.10
Full-year 2025 adjusted EBITDA margin guidance raised to approximately 33% from 32%
Q4 2025 revenue guidance of $207 million to $211 million; adjusted EBITDA of $77 million to $81 million
Essent Group reported third-quarter 2025 net income of $164.2 million, or $1.67 per diluted share, down from $176.2 million, or $1.65 per diluted share, a year earlier. Total revenues were $311.8 million, compared with $316.6 million in the prior-year quarter, and the Board declared a $0.31 quarterly dividend and approved a new $500 million share repurchase authorization.
Net income was $164.2 million versus $176.2 million a year earlier, while diluted EPS rose to $1.67 from $1.65.
Total revenues were $311.8 million versus $316.6 million in Q3 2024.
Quarterly dividend of $0.31 per share is payable December 10, 2025, to holders of record on December 1, 2025.
Through October 31, the company had repurchased 8.7 million shares for $501 million; a $500 million authorization runs through year-end 2027.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.